Laboratory News and Research

RSS

ASI launches GenASIs advanced cytogenetic and pathology platforms

Applied Spectral Imaging announced today general availability of the GenASIs automated imaging platforms for genetic and pathology analysis.

19 Dec 2011

Scientists discover a way to keep normal and cancer cells alive in the lab

In a major step that could revolutionize biomedical research, scientists have discovered a way to keep normal cells as well as tumor cells taken from an individual cancer patient alive in the laboratory - which previously had not been possible. Normal cells usually die in the lab after dividing only a few times, and many common cancers will not grow, unaltered, outside of the body.

19 Dec 2011

Engineers describe novel method that collates trace heavy metals in water

An unfortunate consequence of many industrial and manufacturing practices, from textile factories to metalworking operations, is the release of heavy metals in waterways. Those metals can remain for decades, even centuries, in low but still dangerous concentrations.

17 Dec 2011

Researchers demonstrate laser transmission spectroscopy

A team of researchers from the University of Notre Dame have demonstrated a novel DNA detection method that could prove suitable for many real-world applications.

17 Dec 2011

Gladstone Senior Investigator named AAAS fellow for cardiac and stem cell research

The American Association for the Advancement of Science (AAAS) has named Gladstone Senior Investigator Deepak Srivastava, MD, a Fellow for his efforts to advance science and its applications.

17 Dec 2011

TAU researcher develops capsule endoscope to investigate digestive system

Endoscopes - small cameras or optic fibres that are usually attached to flexible tubing designed to investigate the interior of the body - can be dangerously invasive. Procedures often require sedative medications and some recovery time. Now a researcher at Tel Aviv University is developing a "capsule endoscope" that can move through the digestive tract to detect problems independent of any attachments.

16 Dec 2011

Soligenix secures Harvard option rights to initiate anthrax vaccine development program

Soligenix, Inc., a development stage biopharmaceutical company, announced today that it has initiated a next generation anthrax vaccine development program pursuant to a field-exclusive option agreement with Harvard University to negotiate a license under patent rights that cover prophylactic uses of a modified anthrax toxin protein.

16 Dec 2011

Wistar to develop new drug against EBV-associated cancers

The Wistar Institute today announced that it has signed a funding agreement with the Wellcome Trust, a United Kingdom-based charity, to support the development of a new drug to treat cancers associated with Epstein-Barr virus.

16 Dec 2011

Study unveils mechanisms behind neurological effects of penitrem A

The mould fungus Penicillium crustosum occurs relatively frequently in food and animal fodder stored in temperate conditions. This mould produces powerful neurotoxins, for example penitrem A, which causes symptoms that are difficult to distinguish from those of other neurological diseases.

16 Dec 2011

New book on clinical laboratory mycological identification

A new edition of the definitive practical resource for laboratory identification of fungal infections is now available. "The fully revised Medically Important Fungi: A Guide to Identification, 5th Edition," published by ASM Press, offers step-by-step guidance and textual descriptions that allow both novice and experienced lab technologists to accurately distinguish between fungi that display similar characteristics.

16 Dec 2011

Cancer-causing potential of fetal exposure to carcinogens can vary substantially

The cancer-causing potential of fetal exposure to carcinogens can vary substantially, a recent study suggests, causing different types of problems much later in life depending on the stage of pregnancy when the fetus is exposed.

16 Dec 2011

Hologic receives FDA approval for Cervista HTA system to detect cervical cancer

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today that the U.S. Food and Drug Administration (FDA) has approved its Cervista HTA (high throughput automation) system for use with the Company's previously approved Cervista human papillomavirus (HPV) HR test.

From Hologic, Inc. 16 Dec 2011

Study: Many prescription drugs use phthalates as inactive ingredients

Researchers from Boston University's Slone Epidemiology Center (SEC), in collaboration with Harvard School of Public Health, have found numerous prescription and over-the-counter drugs and supplements use certain chemicals called phthalates as inactive ingredients in their products.

15 Dec 2011

FIND, NUS collaborate to identify novel biomarkers for TB diagnosis

A research team from the National University of Singapore (NUS) Singapore Lipidomics Incubator (SLING) is collaborating with the Foundation for Innovative New Diagnostics (FIND) to identify novel target molecules to be employed as biomarkers for the detection of active tuberculosis.

15 Dec 2011

Roundtable discussion about caffeine and physical performance

Caffeine is regarded by some as being a potent stimulant, but the debate continues as to whether it enhances exercise performance. A range of expert opinions capture the scope of this ongoing debate in an informative roundtable discussion published in Journal of Caffeine Research, a quarterly peer-reviewed journal from Mary Ann Liebert, Inc.

15 Dec 2011

Lab results change in consistent ways during the course of Kawasaki disease

Children with Kawasaki disease show a pattern of changing laboratory test results as the disease runs its course, according to a study in the December issue of The Pediatric Infectious Disease Journal.

15 Dec 2011

SU2C, MRA announce new Dream Team dedicated to melanoma research

Stand Up To Cancer (SU2C), the Melanoma Research Alliance (MRA) and SU2C's scientific partner, the American Association for Cancer Research (AACR), today announced a new Dream Team dedicated to melanoma research. Jeffrey M. Trent, Ph.D., and Patricia M. LoRusso, D.O., will lead the Dream Team project entitled "Personalized Medicine for Patients with BRAF Wild-Type (BRAFwt) Cancer."

15 Dec 2011

Lockheed Martin, Johns Hopkins partner to create safer and more efficient ICU model

The Armstrong Institute for Patient Safety and Quality of Johns Hopkins Medicine is collaborating with the Lockheed Martin Corporation, a global security and technology company, to create a safer and more efficient hospital intensive care unit (ICU) model.

15 Dec 2011

New drug candidate may halt mental decline of Alzheimer's

A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published today in PLoS one.

15 Dec 2011

Sartorius acquires liquid handling business from Biohit Oyj

Yesterday Sartorius, a leading international process and laboratory technology provider, successfully completed its acquisition of the liquid handling business of the Finnish laboratory supplier Biohit Oyj.

From Sartorius 15 Dec 2011